The DOI matches its Crossref record; 142 of the 143 references it cites were found in a registry or an index.
Atherosclerosis--an inflammatory disease
Abstract
Atherosclerosis is an inflammatory disease. Because high plasma concentrations of cholesterol, in particular those of low-density lipoprotein (LDL) cholesterol, are one of the principal risk factors for atherosclerosis,1 the process of atherogenesis has been considered by many to consist largely of the accumulation of lipids within the artery wall; however, it is much more than that. Despite changes in lifestyle and the use of new pharmacologic approaches to lower plasma cholesterol concentrations,2,3 cardiovascular disease continues to be the principal cause of death in the United States, Europe, and much of Asia.4,5 In fact, the lesions of atherosclerosis represent . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dyslipidaemias are very common in patients who have undergone heart, lung, liver, kidney, or allogenic haematopoietic stem cell transplantation, and predispose such patients to an increased risk of developing ASCVD and transplant arterial vasculopathy [497-501].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [501]
In the citing paper
“Dyslipidaemias are very common in patients who have undergone heart, lung, liver, kidney, or allogenic haematopoietic stem cell transplantation, and predispose such patients to an increased risk of developing ASCVD and transplant arterial vasculopathy [497-501].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [501]
In the citing paper
“an established risk factor for CVD (8, 28).”
From Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial (2014) · cites this paper as [28]
In the citing paper
“Sterile inflammation is also an important component of atherosclerosis, as engulfment of cholesterol crystals by macrophages leads to the activation and recruitment of inflammatory cells, endothelial cell dysfunction and plaque formation5.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [5]
In the citing paper
“Crystal-induced arthropathies, such as gout, are associated with elevated IL-1β production, which leads to joint inflammation and destruction5.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Self-citationPrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Self-citationEffects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries
Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R., & Kolettis, G. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162204 · Cited by 3,623
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Research works printed but not linked: 29
- 1994, Lancet, 344, 1383
- Ross R, 1993, Am J Pathol, 143, 987
- Simionescu N, 1986, Am J Pathol, 123, 109
- Stary HC. The histological classification of atherosclerotic lesions in human coronary arteries. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996:463-74.
- van der Wal AC, 1989, Lab Invest, 61, 166
- Libby P, Ross R. Cytokines and growth regulatory molecules. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996:585-94.
- Raines EW, Rosenfeld ME, Ross R. The role of macrophages. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996:539-55.
- Falk E, Shah PK, Fuster V. Pathogenesis of plaque disruption. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 2. Philadelphia: Lippincott-Raven, 1996:492-510.
- Griendling KK, 1997, Circulation, 96, 3264
- Geng Y-J, 1995, Am J Pathol, 147, 251
- Palkama T, 1991, Immunology, 74, 432
- McCully KS, 1969, Am J Pathol, 56, 111
- Mudd SH, 1985, Am J Hum Genet, 37, 1
- Chobanian AV, Dzau VJ. Renin angiotensin system and atherosclerotic vascular disease. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996:237-42.
- Hendrix MG, 1990, Am J Pathol, 136, 23
- Jackson LA, 1997, Am J Pathol, 150, 1785
- Melnick JL, 1993, Eur Heart J, 14, 30
- Hajjar DP, 1986, Am J Pathol, 122, 62
- Gotlieb AI, Langille BL. The role of rheology in atherosclerotic coronary artery disease. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996:595-606.
- Springer TA, Cybulsky MI. Traffic signals on endothelium for leukocytes in health, inflammation, and atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996:511-38.
- Giachelli CM, 1998, Am J Pathol, 152, 353
- Hansson GK, Libby P. The role of the lymphocyte. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol. 1. Philadelphia: Lippincott-Raven, 1996:557-68.
- Davies MJ, 1990, Circulation, 82, II
- Libby P, 1991, Lab Invest, 64, 5
- Anthony PP, 1977, Bull World Health Organ, 55, 521
- Johnson RJ, 1997, Am J Pathol, 151, 1179
- DiMagno EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas: biology, pathobiology, and disease. 2nd ed. New York: Raven Press, 1993:665-706.
- Babaev VR, 1990, Am J Pathol, 136, 1031
- Qiao J-H, 1997, Am J Pathol, 150, 1687
Cited by
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Metadata
- Authors
- Ross, R.
- Affiliations
- University of Washington (US)
- Corresponding author
- Ross, Russell
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1999-01-14
- Volume
- 340
- Issue
- 2
- Pages
- 115-126
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2324841714
- Cited by
- 21,725
- References
- 143
- Citations by year
- 2026: 231 · 2025: 350 · 2024: 391 · 2023: 476 · 2022: 522 · 2021: 565 · 2020: 559 · 2019: 573 · 2018: 630 · 2017: 625 · 2016: 703 · 2015: 808 · 2014: 849 · 2013: 949 · 2012: 1042
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-18645, P01HL018645)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, inflammation, atherogenesis, LDL cholesterol, serum cholesterol, cardiovascular disease
- MeSH terms
- Arteriosclerosis, Blood Platelets, Endothelium, Vascular, Humans, Hypercholesterolemia, Hypertension, Inflammation, Lipoproteins, LDL, Monocytes, Muscle, Smooth, Vascular, T-Lymphocytes, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atherosclerosis--an inflammatory disease. https://app.cochat.ai/papers/10.1056/nejm199901143400207
- The paper
- Ross, R. (1999). Atherosclerosis--an inflammatory disease. New England Journal of Medicine. https://doi.org/10.1056/nejm199901143400207
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.